Literature DB >> 1670647

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene.

R A Riemersma1, D A Wood, C C Macintyre, R A Elton, K F Gey, M F Oliver.   

Abstract

The relation between risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene was examined in a population case-control study of 110 cases of angina, identified by the Chest Pain Questionnaire, and 394 controls selected from a sample of 6000 men aged 35-54. Plasma concentrations of vitamins C and E and carotene were significantly inversely related to the risk of angina. There was no significant relation with vitamin A. Smoking was a confounding factor. The inverse relation between angina and low plasma carotene disappeared and that with plasma vitamin C was substantially reduced after adjustment for smoking. Vitamin E remained independently and inversely related to the risk of angina after adjustment for age, smoking habit, blood pressure, lipids, and relative weight. The adjusted odds ratio for angina between the lowest and highest quintiles of vitamin E concentrations was 2.68 (95% confidence interval 1.07-6.70; p = 0.02). These findings suggest that some populations with a high incidence of coronary heart disease may benefit from eating diets rich in natural antioxidants, particularly vitamin E.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670647     DOI: 10.1016/0140-6736(91)93327-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  70 in total

1.  Effects of vitamin E on human platelet and mononuclear cell responses in vitro.

Authors:  J C Williams; L A Forster; S P Tull; G A Ferns
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

2.  Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients.

Authors:  P I Oteiza; O D Uchitel; F Carrasquedo; A L Dubrovski; J C Roma; C G Fraga
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 3.  Should antioxidant status be considered in interventional trials with antioxidants?

Authors:  F Violi; L Loffredo; L Musella; A Marcoccia
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

4.  The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.

Authors:  S Devaraj; D Li; I Jialal
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Beta-carotene intake and risk of nonfatal acute myocardial infarction in women.

Authors:  A Tavani; E Negri; B D'Avanzo; C La Vecchia
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

6.  Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet.

Authors:  U Tröger; F P Meyer
Journal:  BMJ       Date:  1998-10-17

7.  Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.

Authors:  S Lepage; D Bonnefont-Rousselot; E Bruckert; B Bourely; M C Jaudon; J Delattre; U Assogba
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

8.  Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages.

Authors:  H Shige; T Ishikawa; M Suzukawa; M Nishiwaki; T Yamashita; K Nakajima; T Ito; K Higashi; M Ayaori; A Yonemura; P Nestel; H Nakamura
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

9.  [Vitamin E distribution of lipoproteins in patients with coronary heart disease].

Authors:  T Purcz; W Reuter; B Vorberg; I Sauer; A Neugebauer
Journal:  Z Ernahrungswiss       Date:  1996-09

Review 10.  Antiatherogenic effects of vitamin E: the search for the Holy Grail.

Authors:  Dimitrios Kirmizis; Dimitrios Chatzidimitriou
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.